title: Phosphatidylinositol 3-kinase in HL-60 nuclei is bound to the nuclear matrix and increases during granulocytic differentiation.
abstract: We have used HL-60 leukemia cells to investigate phosphatidylinositol 3-kinase (PI 3-K) during granulocytic differentiation at the nuclear level. Nuclei of HL-60 cells showed a constitutive presence of PI 3-K that increased when cells were treated with differentiating doses of ATRA. PI 3-K was also detected tightly bound to nuclear matrices of HL-60 cells, isolated by nuclease treatment and high salt extraction. Four days of ATRA treatment induced a striking increase of nuclear matrix bound PI 3-K. In situ morphological analysis by confocal microscopy showed the translocation of PI 3-K to the nucleus and to the subnuclear fractions. PI 3-K enzymatic activity was stimulated during the granulocytic differentiation process and parallelled the increase in content of nuclei and subnuclear fractions. PI 3-K activity was recovered in nuclei also without the addition of exogenous substrates, consistent with the presence of both substrates and enzyme in the nucleus. These results indicate that specific intracellular localization of PI 3-K determines the production of different phosphoinositides in the sites of the enzyme translocation, and suggest that 3-phosphoinositide metabolism may play a specific role in the nucleus, candidating PI 3-K as a key enzyme in promoting granulocytic differentiation of HL-60 cells.
authors.affiliation: Section of Human Anatomy, University of Ferrara, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Marchisio
authors.forename: V
authors.initials: V
authors.lastname: Bertagnolo
authors.forename: M L
authors.initials: ML
authors.lastname: Colamussi
authors.forename: S
authors.initials: S
authors.lastname: Capitani
authors.forename: L M
authors.initials: LM
authors.lastname: Neri
mesh_terms: D015153:Blotting, Western; D002454:Cell Differentiation / Q000187:drug effects; D019085:Fluorescent Antibody Technique, Direct; D006098:Granulocytes / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D018922:HL-60 Cells / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007150:Immunohistochemistry; D018613:Microscopy, Confocal; D015530:Nuclear Matrix / Q000201:enzymology* / Q000378:metabolism / Q000473:pathology; D019869:Phosphatidylinositol 3-Kinases / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D013347:Subcellular Fractions / Q000201:enzymology / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology
chemical_list: D014212:Tretinoin; D019869:Phosphatidylinositol 3-Kinases